Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
– ARV-102 was well tolerated in clinical trials for both healthy volunteers and patients with Parkinson’s disease – – ARV-102 demonstrated dose-dependent cerebrospinal fluid (CSF) exposure in subjects ...
More than 20,000 people across the UK could be living with undiagnosed Parkinson’s disease, a new study has revealed. The ...
Parkinson's Disease affects around a million people in the United States, and that number is on the rise, in part because our population is getting older. Dr. Claire Henchcliffe is the chair of ...
A common chemical that is widespread in the U.S. has been linked to an increased risk of Parkinson’s disease, researchers say. In a recent study published in the journal Neurology, researchers found a ...
4don MSN
Women better protected against early neurodegeneration in Parkinson's disease, study reveals
A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback